These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis. Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784 [TBL] [Abstract][Full Text] [Related]
14. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis]. Xu KF; Chen Y; Guo ZJ; Zhu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782 [TBL] [Abstract][Full Text] [Related]
15. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Carraway MS; Ghio AJ; Carter JD; Piantadosi CA Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326 [TBL] [Abstract][Full Text] [Related]
16. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Venkateshiah SB; Yan TD; Bonfield TL; Thomassen MJ; Meziane M; Czich C; Kavuru MS Chest; 2006 Jul; 130(1):227-37. PubMed ID: 16840407 [TBL] [Abstract][Full Text] [Related]
17. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Tazawa R; Trapnell BC; Inoue Y; Arai T; Takada T; Nasuhara Y; Hizawa N; Kasahara Y; Tatsumi K; Hojo M; Ishii H; Yokoba M; Tanaka N; Yamaguchi E; Eda R; Tsuchihashi Y; Morimoto K; Akira M; Terada M; Otsuka J; Ebina M; Kaneko C; Nukiwa T; Krischer JP; Akazawa K; Nakata K Am J Respir Crit Care Med; 2010 Jun; 181(12):1345-54. PubMed ID: 20167854 [TBL] [Abstract][Full Text] [Related]
18. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617 [TBL] [Abstract][Full Text] [Related]
19. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Seymour JF; Doyle IR; Nakata K; Presneill JJ; Schoch OD; Hamano E; Uchida K; Fisher R; Dunn AR Thorax; 2003 Mar; 58(3):252-7. PubMed ID: 12612307 [TBL] [Abstract][Full Text] [Related]
20. [Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage]. Ueda Y; Matsuo K; Tsushima M; Mizuta M; Fujiwara K; Yonei T; Sato T Nihon Kokyuki Gakkai Zasshi; 2009 Sep; 47(9):833-8. PubMed ID: 19827590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]